Olopatadine
Allergy · OTC (0.1%, 0.2%, 0.7%)
OTCAllergy
| Strength | 0.1% (BID), 0.2% (QD), 0.7% (QD, Pazeo) |
|---|---|
| Typical quantity | 2.5-5 mL bottle, mostly OTC now |
| Cash cost / month | Low · ~$0-20 |
| Drug class | Antihistamine + mast-cell stabilizer (dual-acting) |
| Mechanism of action | Selective H1-antagonist with mast-cell stabilizing activity; inhibits histamine release and downstream mediator cascade. |
| Indication / reason for use | Allergic conjunctivitis, ocular itching, redness, chemosis; seasonal and perennial. |
| Usual adult dosing | 0.1% one drop in each eye twice daily; 0.2%/0.7% one drop once daily. |
| Preservative | BAK 0.01% |
| Contact lenses | Remove lenses before use; wait 10-15 min before reinserting. Do not use to treat lens-related irritation. |
| Common / important adverse effects | Headache, mild burning, dry eye, dysgeusia (higher strengths). |
| Contraindications & cautions | Hypersensitivity. |
| Pregnancy / lactation | Limited data; considered acceptable when needed. |
| Trade names | Pataday Once Daily / Twice Daily, Patanol, Pazeo |
| Practice notes | Dual-acting agents work best when started before the allergy season. |
Chair-side reference only. Dosing, contraindications and pregnancy guidance here are not exhaustive. Confirm against the current prescribing information and the patient’s full history before prescribing or advising.